At GSK, we believe in pricing our medicines in a way that allows as many people around the world as possible to have access to the medicines or treatments that are right for them. That included the many patients in the United States.
In establishing our prices in the US, we strive to balance the benefits of our medicines or vaccines compared to alternative products, all while also trying to account for the risk, time, and cost of drug development and generating affordable access for patients.
Our goal is to ensure that we are working in the best interest of both our patients and shareholders. The prices of our products reflect this commitment.